Articoli con mandati relativi all'accesso pubblico - Robert F StoreyUlteriori informazioni
Non disponibili pubblicamente: 26
The role of platelets in inflammation
MR Thomas, RF Storey
Thrombosis and haemostasis 114 (09), 449-458, 2015
Mandati: UK Medical Research Council
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction
J Silvain, RF Storey, G Cayla, JB Esteve, JG Dillinger, H Rousseau, ...
Thrombosis and haemostasis 116 (08), 369-378, 2016
Mandati: National Institute of Health and Medical Research, France
Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function
HM Judge, RJ Buckland, A Sugidachi, JA Jakubowski, RF Storey
Thrombosis and haemostasis 103 (06), 1210-1217, 2010
Mandati: British Heart Foundation
The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses
HM Judge, RJ Buckland, A Sugidachi, JA Jakubowski, RF Storey
Platelets 19 (2), 125-133, 2008
Mandati: British Heart Foundation
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
D Capodanno, U Baber, DL Bhatt, JP Collet, G Dangas, F Franchi, ...
Nature Reviews Cardiology 19 (12), 829-844, 2022
Mandati: US National Institutes of Health
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes
G Ducrocq, PJ Schulte, A Budaj, JH Cornel, C Held, A Himmelmann, ...
American heart journal 186, 91-99, 2017
Mandati: National Institute of Health and Medical Research, France
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA• CER) trial: study design and rationale
TRA The, CER Executive, S Committees
American Heart Journal 158 (3), 327-334. e4, 2009
Mandati: US National Institutes of Health
Biomarkers and coronary lesions predict outcomes after revascularization in non–ST-elevation acute coronary syndrome
D Lindholm, SK James, M Bertilsson, RC Becker, CP Cannon, ...
Clinical chemistry 63 (2), 573-584, 2017
Mandati: US National Institutes of Health
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: analysis from the …
YJ Shimada, S Bansilal, SD Wiviott, RC Becker, RA Harrington, ...
American heart journal 177, 1-8, 2016
Mandati: US National Institutes of Health, American Heart Association
Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors
MR Thomas, RF Storey
Vascular pharmacology 84, 25-27, 2016
Mandati: UK Medical Research Council
Antithrombotic therapy for patients with chronic coronary syndromes
WAE Parker, RF Storey
Heart 107 (11), 925-933, 2021
Mandati: British Heart Foundation
Design and rationale of the COMPLETE trial: a randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat …
SR Mehta, DA Wood, B Meeks, RF Storey, R Mehran, KR Bainey, ...
American Heart Journal 215, 157-166, 2019
Mandati: Canadian Institutes of Health Research
Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis–Task Force on Anticoagulants in Heart Disease
R De Caterina, S Husted, L Wallentin, F Andreotti, H Arnesen, ...
Thrombosis and Haemostasis 115 (04), 685-711, 2016
Mandati: UK Medical Research Council
Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes
MR Thomas, RF Storey
Journal of cardiovascular translational research 7, 19-28, 2014
Mandati: UK Medical Research Council
Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes
RR Joshi, R Hossain, AC Morton, R Ecob, HM Judge, C Wales, JV Walker, ...
Platelets 25 (6), 416-422, 2014
Mandati: National Institute for Health Research, UK
Novel approaches to P2Y12 inhibition and aspirin dosing
WAE Parker, RF Storey
Platelets 32 (1), 7-14, 2021
Mandati: British Heart Foundation
Genetics of response to antiplatelet therapy
MR Thomas, RF Storey
Progress in molecular biology and translational science 124, 123-153, 2014
Mandati: UK Medical Research Council
Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the …
M Ono, M Tomaniak, W Koenig, R Khamis, R de Silva, P Chichareon, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (1), 39-47, 2022
Mandati: British Heart Foundation
Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: Effects on platelet function and cellular adenosine uptake
KW Ow, WAE Parker, MM Porter, J Hanson, HM Judge, NP Briffa, ...
Platelets 31 (7), 945-951, 2020
Mandati: British Heart Foundation, National Institute for Health Research, UK
Combining DAPT with a PPI faces the acid test of real-world use
WAE Parker, RF Storey
European Heart Journal 40 (24), 1971-1974, 2019
Mandati: British Heart Foundation
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software